Find Grants for Advance Search
Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.
Chemical Evolution of the Solid Earth and Volcanology
No deadline specified
Opportunity Number: 25-516
Agency: U.S. National Science Foundation
Open Date: December 10, 2024
Status: Posted
CFDA Numbers: 47.050
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-321
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
Deadline: September 28, 2026
Opportunity Number: PAR-25-156
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 93.350
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
Deadline: September 28, 2027
Opportunity Number: PAR-25-196
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: September 28, 2027
Status: Posted
CFDA Numbers: 93.350
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Deadline: June 15, 2026
Opportunity Number: RFA-EY-25-001
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: June 15, 2026
Status: Posted
CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline: November 2, 2026
Opportunity Number: PAR-24-280
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline: November 2, 2026
Opportunity Number: PAR-24-279
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
HARMONY: Human-Centric Analytics for Resilient & Modernized Power sYstems
Deadline: April 9, 2026
Opportunity Number: DE-FOA-0003446
Agency: National Energy Technology Laboratory
Open Date: December 9, 2024
Close Date: April 9, 2026
Status: Posted
CFDA Numbers: 81.122
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
Deadline: May 28, 2027
Opportunity Number: PAR-25-197
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: May 28, 2027
Status: Posted
CFDA Numbers: 93.350
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: March 4, 2027
Opportunity Number: PAR-25-141
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: March 4, 2027
Status: Posted
CFDA Numbers: 93.846
Life and Environments Through Time
No deadline specified
Opportunity Number: 25-517
Agency: U.S. National Science Foundation
Open Date: December 7, 2024
Status: Posted
CFDA Numbers: 47.050
Structure and Physics of the Solid Earth
No deadline specified
Opportunity Number: 25-518
Agency: U.S. National Science Foundation
Open Date: December 7, 2024
Status: Posted
CFDA Numbers: 47.050
Water, Landscape, and Critical Zone Processes
No deadline specified
Opportunity Number: 25-519
Agency: U.S. National Science Foundation
Open Date: December 7, 2024
Status: Posted
CFDA Numbers: 47.050
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-330
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-100
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.279
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Deadline: June 2, 2026
Opportunity Number: RFA-TR-25-002
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: June 2, 2026
Status: Posted
CFDA Numbers: 93.350
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-298
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.839, 93.173, 93.279, 93.840, 93.273, 93.395, 93.855, 93.865, 93.233, 93.853, 93.361, 93.121, 93.393, 93.172, 93.399, 93.866, 93.846, 93.837, 93.838, 93.396, 93.351, 93.394, 93.242, 93.213, 93.867, 93.113, 93.286
Security, Privacy, and Trust in Cyberspace
Deadline: September 28, 2026
Opportunity Number: 25-515
Agency: U.S. National Science Foundation
Open Date: December 6, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 47.075, 47.076, 47.049, 47.070
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-055
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-056
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-299
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.273, 93.307, 93.399
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-025
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.233, 93.837
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-026
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-239
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: November 5, 2027
Opportunity Number: PAR-25-297
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.866
